The New England Journal of Medicine | Research & Review Articles …
WEBThe New England Journal of Medicine (NEJM) is a weekly general medical journal that publishes new medical research and review articles, and editorial opinion on a wide variety of topics of ...
Coronavirus (Covid-19) | NEJM - The New England Journal of …
WEBJul 17, 2024 · Explore a collection of articles and other resources on the Coronavirus (Covid-19) outbreak, including clinical reports, management guidelines, and commentary.
Effect of Early Treatment with Ivermectin among Patients with …
WEBMar 30, 2022 · The efficacy of ivermectin in preventing hospitalization or extended observation in an emergency setting among outpatients with acutely symptomatic coronavirus disease 2019 (Covid-19), the disease ...
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
WEBDec 10, 2020 · A two-dose regimen of BNT162b2 (30 μg per dose, given 21 days apart) was found to be safe and 95% effective against Covid-19. The vaccine met both primary efficacy end points, with more than a 99 ...
Toxic Effects from Ivermectin Use Associated with Prevention and ...
WEBOct 20, 2021 · The Oregon Poison Center received calls at a rate of 0.25 per month in all of 2020, as compared with 21 calls in August 2021 alone, regarding toxic effects from ivermectin in persons who used the d...
Rapid Diagnostic Testing for SARS-CoV-2 - The New England …
WEBJan 7, 2022 · Rapid Diagnostic Testing for SARS-CoV-2. •. Rapid diagnostic tests (RDTs) that are authorized by the Food and Drug Administration to diagnose severe acute respiratory syndrome coronavirus 2 ...
Pulmonary Embolism | New England Journal of Medicine
WEBJul 6, 2022 · Evaluation of pulmonary embolism includes assessment of clinical probability and, if indicated, d-dimer testing. Most patients with low-risk pulmonary embolism can be treated with oral anticoagulants.
Semaglutide and Cardiovascular Outcomes in Patients with Type 2 ...
WEBSep 16, 2016 · Regulatory guidance specifies the need to establish cardiovascular safety of new diabetes therapies in patients with type 2 diabetes in order to rule out excess cardiovascular risk. The cardiovascu...
Ivermectin Treatment for Covid-19 - The New England Journal of …
WEBDec 14, 2022 · Reis et al. conclude that ivermectin is ineffective for the treatment of Covid-19. However, they found the treatment to be safe, with no significant differences in the incidence of adverse events ...
Efficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of …
WEBSep 22, 2021 · At interim analysis in a phase 3, observer-blinded, placebo-controlled clinical trial, the mRNA-1273 vaccine showed 94.1% efficacy in preventing coronavirus disease 2019 (Covid-19). After emergency...